VIPLUSMA Trademark

Trademark Overview

On Tuesday, January 14, 2020, a trademark application was filed for VIPLUSMA with the United States Patent and Trademark Office. The USPTO has given the VIPLUSMA trademark a serial number of 88758608. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 30, 2023. This trademark is owned by ENDOCYTE, INC.. The VIPLUSMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer
viplusma

General Information

Serial Number88758608
Word MarkVIPLUSMA
Filing DateTuesday, January 14, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 30, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameENDOCYTE, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Lafayette, IN 47906
Party NameENDOCYTE, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Lafayette, IN 47906

Trademark Events

Event DateEvent Description
Monday, January 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 30, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, June 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 22, 2022SOU EXTENSION 4 GRANTED
Wednesday, June 22, 2022SOU EXTENSION 4 FILED
Wednesday, June 22, 2022TEAS EXTENSION RECEIVED
Thursday, December 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 28, 2021SOU EXTENSION 3 GRANTED
Tuesday, December 28, 2021SOU EXTENSION 3 FILED
Tuesday, December 28, 2021TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 18, 2021SOU EXTENSION 2 GRANTED
Friday, June 18, 2021SOU EXTENSION 2 FILED
Friday, June 18, 2021TEAS EXTENSION RECEIVED
Thursday, December 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 22, 2020SOU EXTENSION 1 GRANTED
Tuesday, December 22, 2020SOU EXTENSION 1 FILED
Tuesday, December 22, 2020TEAS EXTENSION RECEIVED
Friday, October 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 30, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 31, 2020ASSIGNED TO EXAMINER
Tuesday, January 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 17, 2020NEW APPLICATION ENTERED

Related Keywords

viplusma pharmaceutical diseases treatment oncological preparations delivery facilitate compounds wide treat